Appendix B Table 4 Inclusion or Exclusion of Articles From the 2003 U.S. Preventive Services Task Force Review, Medication Trials

Author, YearIncluded for
KQs 1–3
Reason for ExclusionIncluded for
KQ 4
Reason for Exclusion
James, 2000Sibutramine studySibutramine study
Fujioka, 2000Sibutramine studySibutramine study
Gokcel, 2001Sibutramine studySibutramine study
Smith, 2001Sibutramine studySibutramine study
Wirth, 2001Sibutramine studySibutramine study
Dujovne, 2001Sibutramine studySibutramine study
Van Gaal, 1998<12 months of followupXNA
Hill, 1999XNAXNA
Karhunen, 2000XNA*XNA*
Micic, 1999<12 months of followupNo harms outcomes
Muls, 2001<12 months of followupXNA
Giugliano, 1993<12 months of followupNo harms outcomes
Rissanen, 1998XNA*XNA*

* Secondary article to an included article.

Abbreviations: KQ=key question; NA=not applicable.

From: Appendix B, Search Strategies

Cover of Screening for and Management of Obesity and Overweight in Adults
Screening for and Management of Obesity and Overweight in Adults [Internet].
Evidence Syntheses, No. 89.
LeBlanc E, O'Connor E, Whitlock EP, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.